CAMP4 Therapeutics Corp. (CAMP)
4.00
-0.10
(-2.44%)
USD |
NASDAQ |
Nov 19, 16:00
3.94
-0.06
(-1.50%)
After-Hours: 20:00
CAMP4 Therapeutics Price : 4.00 for Nov. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | 4.15 | 4.249 | 3.74 | 4.00 | 207469.0 |
| Nov 18, 2026 | 3.93 | 4.35 | 3.81 | 4.10 | 194718.0 |
| Nov 17, 2026 | 3.90 | 4.09 | 3.87 | 4.00 | 216292.0 |
| Nov 16, 2026 | 3.83 | 4.08 | 3.58 | 3.86 | 108684.0 |
| Nov 13, 2026 | 4.13 | 4.13 | 3.75 | 3.80 | 46161.00 |
| Nov 12, 2026 | 4.19 | 4.30 | 3.98 | 4.09 | 62417.00 |
| Nov 11, 2026 | 4.41 | 4.415 | 4.13 | 4.20 | 95224.00 |
| Nov 10, 2026 | 4.63 | 4.63 | 4.25 | 4.33 | 109021.0 |
| Nov 09, 2026 | 4.16 | 4.97 | 3.990 | 4.69 | 374450.0 |
| Nov 06, 2026 | 3.72 | 4.06 | 3.66 | 4.06 | 128682.0 |
| Nov 05, 2026 | 3.80 | 3.875 | 3.54 | 3.72 | 191111.0 |
| Nov 04, 2026 | 4.01 | 4.01 | 3.73 | 3.74 | 126772.0 |
| Nov 03, 2026 | 3.82 | 4.00 | 3.79 | 3.83 | 134398.0 |
| Nov 02, 2026 | 4.02 | 4.15 | 3.71 | 3.775 | 171221.0 |
| Oct 30, 2026 | 3.87 | 4.005 | 3.775 | 3.96 | 137998.0 |
| Oct 29, 2026 | 3.69 | 3.990 | 3.66 | 3.90 | 151977.0 |
| Oct 28, 2026 | 3.65 | 3.66 | 3.48 | 3.65 | 99173.00 |
| Oct 27, 2026 | 3.26 | 3.755 | 3.25 | 3.65 | 260819.0 |
| Oct 26, 2026 | 3.32 | 3.32 | 3.19 | 3.21 | 60108.00 |
| Oct 23, 2026 | 3.39 | 3.39 | 3.21 | 3.30 | 284947.0 |
| Oct 22, 2026 | 3.20 | 3.50 | 3.195 | 3.39 | 141127.0 |
| Oct 21, 2026 | 3.17 | 3.33 | 2.96 | 3.29 | 186414.0 |
| Oct 20, 2026 | 3.18 | 3.38 | 3.11 | 3.16 | 89175.00 |
| Oct 19, 2026 | 3.20 | 3.41 | 3.11 | 3.14 | 57711.00 |
| Oct 16, 2026 | 3.45 | 3.45 | 3.17 | 3.17 | 92419.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 17.59 |
| Alnylam Pharmaceuticals, Inc. | 147.82 |
| Anika Therapeutics, Inc. | 13.28 |
| Savara, Inc. | 5.21 |
| Arrowhead Pharmaceuticals, Inc. | 43.65 |
Price Related Metrics
| PS Ratio | 46.37 |
| Price to Book Value | 2.344 |
| Earnings Yield | -50.96% |
| Market Cap | 251.02M |